 | • レポートコード：MRC308GR11341 • 出版社/出版日：GlobalInfoResearch / 2023年8月 • レポート形態：英文、PDF、119ページ • 納品方法：Eメール（2-3営業日） • 産業分類：医薬品＆ヘルスケア |
| Single User | ￥522,000 (USD3,480) | ▷ お問い合わせ |
| Corporate User | ￥783,000 (USD5,220) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
GlobalInfoResearchの最新の調査によると、世界のアダリムマブ注射液の市場規模は2022年のxxx米ドルから2029年にはxxx米ドルと推定され、xxx％の成長率で成長すると予想されます。新型コロナウイルス感染症とロシア・ウクライナ戦争の影響を考慮しながら市場規模を推計しました。
このレポートは、世界のアダリムマブ注射液市場に関する詳細かつ包括的な分析の結果です。定量的分析と定性的分析データが、メーカー別、地域別、国別、種類別、用途別に記載されています。
市場は常に変化しているため、本レポートでは、競争、需要と供給の傾向、および多くの市場にわたる需要の変化に影響する主要な要因を調査しました。主要な競合他社の企業概要と製品例、および2023年の市場シェア予測も記載しました。
本レポートの主な目的は次のとおりです。
– 世界および主要国の市場機会の規模を決定するため
– アダリムマブ注射液の成長可能性を評価するため
– 各製品および最終用途市場の将来の成長を予測するため
– 市場に影響を与える競争要因を評価するため
アダリムマブ注射液市場は種類と用途によって区分されます。2018年～2029年において、量と金額の観点から種類別および用途別セグメントの売上予測データを提供します。この分析は、適格なニッチ市場をターゲットにすることでビジネスを拡大するのに役立ちます。
種類別セグメント
・40mg/0.8ml、20mg/0.4ml
用途別セグメント
・病院、診療所、その他
主要な市場プレーヤー
・AbbVie、Amgen、Sandoz、Fresenius Kabi、Biogen、Celltrion、Cadila Pharmaceuticals、Bio-Thera Solutions, Ltd.、Hisun Biopharmaceutical、Innovent Biologics、Mylan、Zydus Group、Boehringer Ingelheim、Jiangsu Chia Tai-Tianqing Pharmaceutical、Shanghai Henlius Biotech
地域別セグメントは次の地域・国をカバーします。
・北米（米国、カナダ、メキシコ）
・ヨーロッパ（ドイツ、フランス、イギリス、ロシア、イタリア）
・アジア太平洋（日本、中国、韓国、インド、東南アジア、オーストラリア）
・南アメリカ（ブラジル、アルゼンチン、コロンビア）
・中東およびアフリカ（サウジアラビア、UAE、エジプト、南アフリカ）
本調査レポートの内容は計15章あります。
・第1章では、アダリムマブ注射液製品の調査範囲、市場の概要、市場の成長要因・阻害要因、および市場動向について説明します。
・第2章では、主要なアダリムマブ注射液メーカーの企業概要、2019年～2022年までのアダリムマブ注射液の価格、販売量、売上、市場シェアを掲載しています。
・第3章では、主要なアダリムマブ注射液メーカーの競争状況、販売量、売上、世界市場シェアが重点的に比較分析されています。
・第4章では、2018年～2029年までの地域別アダリムマブ注射液の販売量、売上、成長性を示しています。
・第5、6章では、2018年～2029年までのアダリムマブ注射液の種類別と用途別の市場規模、市場シェアと成長率を掲載しています。
・第7、8、9、10、11章では、2018年～2022年までの世界の主要国での販売量、売上、市場シェア、並びに2023年～2029年までの主要地域でのアダリムマブ注射液市場予測を収録しています。
・第12章では、市場力学、成長要因、阻害要因、トレンド、ポーターズファイブフォース分析、新型コロナウイルス感染症とロシア・ウクライナ戦争の影響を掲載しています。
・第13章では、主要な原材料、主要なサプライヤー、およびアダリムマブ注射液の産業チェーンを掲載しています。
・第14、15章では、アダリムマブ注射液の販売チャネル、販売業者、顧客、調査結果について説明します。
***** 目次(一部) *****
・市場概要
– アダリムマブ注射液の概要
– 種類別分析（2018年vs2022年vs2029年）：40mg/0.8ml、20mg/0.4ml
– 用途別分析（2018年vs2022年vs2029年）：病院、診療所、その他
– 世界のアダリムマブ注射液市場規模・予測
– 世界のアダリムマブ注射液生産能力分析
– 市場の成長要因・阻害要因・動向
・メーカー情報（企業概要、製品概要、販売量、価格、売上）
– AbbVie、Amgen、Sandoz、Fresenius Kabi、Biogen、Celltrion、Cadila Pharmaceuticals、Bio-Thera Solutions, Ltd.、Hisun Biopharmaceutical、Innovent Biologics、Mylan、Zydus Group、Boehringer Ingelheim、Jiangsu Chia Tai-Tianqing Pharmaceutical、Shanghai Henlius Biotech
・メーカー別市場シェア・市場集中度
・地域別市場分析2018年-2029年
・種類別分析2018年-2029年：40mg/0.8ml、20mg/0.4ml
・用途別分析2018年-2029年：病院、診療所、その他
・アダリムマブ注射液の北米市場
– 種類別市場規模2018年-2029年
– 用途別市場規模2018年-2029年
– 主要国別市場規模：アメリカ、カナダ、メキシコなど
・アダリムマブ注射液のヨーロッパ市場
– 種類別市場規模2018年-2029年
– 用途別市場規模2018年-2029年
– 主要国別市場規模：ドイツ、イギリス、フランス、ロシア、イタリアなど
・アダリムマブ注射液のアジア市場
– 種類別市場規模2018年-2029年
– 用途別市場規模2018年-2029年
– 主要国別市場規模：中国、日本、韓国、インド、東南アジア、オーストラリアなど
・アダリムマブ注射液の南米市場
– 種類別市場規模2018年-2029年
– 用途別市場規模2018年-2029年
– 主要国別市場規模：ブラジル、アルゼンチンなど
・アダリムマブ注射液の中東・アフリカ市場
– 種類別市場規模2018年-2029年
– 用途別市場規模2018年-2029年
– 主要国別市場規模：サウジアラビア、トルコ、エジプト、南アフリカなど
・市場力学（成長要因、阻害要因、トレンド、ポーターズファイブフォース分析）
・原材料および産業チェーン
・販売チャネル、流通業者・代理店、顧客リスト
・調査の結果・結論
1 Market Overview
1.1 Product Overview and Scope of Adalimumab Injection
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Adalimumab Injection Consumption Value by Type: 2018 Versus 2022 Versus 2029
1.3.2 40mg/0.8ml
1.3.3 20mg/0.4ml
1.4 Market Analysis by Application
1.4.1 Overview: Global Adalimumab Injection Consumption Value by Application: 2018 Versus 2022 Versus 2029
1.4.2 Hospitals
1.4.3 Clinics
1.4.4 Others
1.5 Global Adalimumab Injection Market Size & Forecast
1.5.1 Global Adalimumab Injection Consumption Value (2018 & 2022 & 2029)
1.5.2 Global Adalimumab Injection Sales Quantity (2018-2029)
1.5.3 Global Adalimumab Injection Average Price (2018-2029)
2 Manufacturers Profiles
2.1 AbbVie
2.1.1 AbbVie Details
2.1.2 AbbVie Major Business
2.1.3 AbbVie Adalimumab Injection Product and Services
2.1.4 AbbVie Adalimumab Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 AbbVie Recent Developments/Updates
2.2 Amgen
2.2.1 Amgen Details
2.2.2 Amgen Major Business
2.2.3 Amgen Adalimumab Injection Product and Services
2.2.4 Amgen Adalimumab Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 Amgen Recent Developments/Updates
2.3 Sandoz
2.3.1 Sandoz Details
2.3.2 Sandoz Major Business
2.3.3 Sandoz Adalimumab Injection Product and Services
2.3.4 Sandoz Adalimumab Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 Sandoz Recent Developments/Updates
2.4 Fresenius Kabi
2.4.1 Fresenius Kabi Details
2.4.2 Fresenius Kabi Major Business
2.4.3 Fresenius Kabi Adalimumab Injection Product and Services
2.4.4 Fresenius Kabi Adalimumab Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 Fresenius Kabi Recent Developments/Updates
2.5 Biogen
2.5.1 Biogen Details
2.5.2 Biogen Major Business
2.5.3 Biogen Adalimumab Injection Product and Services
2.5.4 Biogen Adalimumab Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 Biogen Recent Developments/Updates
2.6 Celltrion
2.6.1 Celltrion Details
2.6.2 Celltrion Major Business
2.6.3 Celltrion Adalimumab Injection Product and Services
2.6.4 Celltrion Adalimumab Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 Celltrion Recent Developments/Updates
2.7 Cadila Pharmaceuticals
2.7.1 Cadila Pharmaceuticals Details
2.7.2 Cadila Pharmaceuticals Major Business
2.7.3 Cadila Pharmaceuticals Adalimumab Injection Product and Services
2.7.4 Cadila Pharmaceuticals Adalimumab Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.7.5 Cadila Pharmaceuticals Recent Developments/Updates
2.8 Bio-Thera Solutions, Ltd.
2.8.1 Bio-Thera Solutions, Ltd. Details
2.8.2 Bio-Thera Solutions, Ltd. Major Business
2.8.3 Bio-Thera Solutions, Ltd. Adalimumab Injection Product and Services
2.8.4 Bio-Thera Solutions, Ltd. Adalimumab Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.8.5 Bio-Thera Solutions, Ltd. Recent Developments/Updates
2.9 Hisun Biopharmaceutical
2.9.1 Hisun Biopharmaceutical Details
2.9.2 Hisun Biopharmaceutical Major Business
2.9.3 Hisun Biopharmaceutical Adalimumab Injection Product and Services
2.9.4 Hisun Biopharmaceutical Adalimumab Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.9.5 Hisun Biopharmaceutical Recent Developments/Updates
2.10 Innovent Biologics
2.10.1 Innovent Biologics Details
2.10.2 Innovent Biologics Major Business
2.10.3 Innovent Biologics Adalimumab Injection Product and Services
2.10.4 Innovent Biologics Adalimumab Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.10.5 Innovent Biologics Recent Developments/Updates
2.11 Mylan
2.11.1 Mylan Details
2.11.2 Mylan Major Business
2.11.3 Mylan Adalimumab Injection Product and Services
2.11.4 Mylan Adalimumab Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.11.5 Mylan Recent Developments/Updates
2.12 Zydus Group
2.12.1 Zydus Group Details
2.12.2 Zydus Group Major Business
2.12.3 Zydus Group Adalimumab Injection Product and Services
2.12.4 Zydus Group Adalimumab Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.12.5 Zydus Group Recent Developments/Updates
2.13 Boehringer Ingelheim
2.13.1 Boehringer Ingelheim Details
2.13.2 Boehringer Ingelheim Major Business
2.13.3 Boehringer Ingelheim Adalimumab Injection Product and Services
2.13.4 Boehringer Ingelheim Adalimumab Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.13.5 Boehringer Ingelheim Recent Developments/Updates
2.14 Jiangsu Chia Tai-Tianqing Pharmaceutical
2.14.1 Jiangsu Chia Tai-Tianqing Pharmaceutical Details
2.14.2 Jiangsu Chia Tai-Tianqing Pharmaceutical Major Business
2.14.3 Jiangsu Chia Tai-Tianqing Pharmaceutical Adalimumab Injection Product and Services
2.14.4 Jiangsu Chia Tai-Tianqing Pharmaceutical Adalimumab Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.14.5 Jiangsu Chia Tai-Tianqing Pharmaceutical Recent Developments/Updates
2.15 Shanghai Henlius Biotech
2.15.1 Shanghai Henlius Biotech Details
2.15.2 Shanghai Henlius Biotech Major Business
2.15.3 Shanghai Henlius Biotech Adalimumab Injection Product and Services
2.15.4 Shanghai Henlius Biotech Adalimumab Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.15.5 Shanghai Henlius Biotech Recent Developments/Updates
3 Competitive Environment: Adalimumab Injection by Manufacturer
3.1 Global Adalimumab Injection Sales Quantity by Manufacturer (2018-2023)
3.2 Global Adalimumab Injection Revenue by Manufacturer (2018-2023)
3.3 Global Adalimumab Injection Average Price by Manufacturer (2018-2023)
3.4 Market Share Analysis (2022)
3.4.1 Producer Shipments of Adalimumab Injection by Manufacturer Revenue ($MM) and Market Share (%): 2022
3.4.2 Top 3 Adalimumab Injection Manufacturer Market Share in 2022
3.4.2 Top 6 Adalimumab Injection Manufacturer Market Share in 2022
3.5 Adalimumab Injection Market: Overall Company Footprint Analysis
3.5.1 Adalimumab Injection Market: Region Footprint
3.5.2 Adalimumab Injection Market: Company Product Type Footprint
3.5.3 Adalimumab Injection Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 Consumption Analysis by Region
4.1 Global Adalimumab Injection Market Size by Region
4.1.1 Global Adalimumab Injection Sales Quantity by Region (2018-2029)
4.1.2 Global Adalimumab Injection Consumption Value by Region (2018-2029)
4.1.3 Global Adalimumab Injection Average Price by Region (2018-2029)
4.2 North America Adalimumab Injection Consumption Value (2018-2029)
4.3 Europe Adalimumab Injection Consumption Value (2018-2029)
4.4 Asia-Pacific Adalimumab Injection Consumption Value (2018-2029)
4.5 South America Adalimumab Injection Consumption Value (2018-2029)
4.6 Middle East and Africa Adalimumab Injection Consumption Value (2018-2029)
5 Market Segment by Type
5.1 Global Adalimumab Injection Sales Quantity by Type (2018-2029)
5.2 Global Adalimumab Injection Consumption Value by Type (2018-2029)
5.3 Global Adalimumab Injection Average Price by Type (2018-2029)
6 Market Segment by Application
6.1 Global Adalimumab Injection Sales Quantity by Application (2018-2029)
6.2 Global Adalimumab Injection Consumption Value by Application (2018-2029)
6.3 Global Adalimumab Injection Average Price by Application (2018-2029)
7 North America
7.1 North America Adalimumab Injection Sales Quantity by Type (2018-2029)
7.2 North America Adalimumab Injection Sales Quantity by Application (2018-2029)
7.3 North America Adalimumab Injection Market Size by Country
7.3.1 North America Adalimumab Injection Sales Quantity by Country (2018-2029)
7.3.2 North America Adalimumab Injection Consumption Value by Country (2018-2029)
7.3.3 United States Market Size and Forecast (2018-2029)
7.3.4 Canada Market Size and Forecast (2018-2029)
7.3.5 Mexico Market Size and Forecast (2018-2029)
8 Europe
8.1 Europe Adalimumab Injection Sales Quantity by Type (2018-2029)
8.2 Europe Adalimumab Injection Sales Quantity by Application (2018-2029)
8.3 Europe Adalimumab Injection Market Size by Country
8.3.1 Europe Adalimumab Injection Sales Quantity by Country (2018-2029)
8.3.2 Europe Adalimumab Injection Consumption Value by Country (2018-2029)
8.3.3 Germany Market Size and Forecast (2018-2029)
8.3.4 France Market Size and Forecast (2018-2029)
8.3.5 United Kingdom Market Size and Forecast (2018-2029)
8.3.6 Russia Market Size and Forecast (2018-2029)
8.3.7 Italy Market Size and Forecast (2018-2029)
9 Asia-Pacific
9.1 Asia-Pacific Adalimumab Injection Sales Quantity by Type (2018-2029)
9.2 Asia-Pacific Adalimumab Injection Sales Quantity by Application (2018-2029)
9.3 Asia-Pacific Adalimumab Injection Market Size by Region
9.3.1 Asia-Pacific Adalimumab Injection Sales Quantity by Region (2018-2029)
9.3.2 Asia-Pacific Adalimumab Injection Consumption Value by Region (2018-2029)
9.3.3 China Market Size and Forecast (2018-2029)
9.3.4 Japan Market Size and Forecast (2018-2029)
9.3.5 Korea Market Size and Forecast (2018-2029)
9.3.6 India Market Size and Forecast (2018-2029)
9.3.7 Southeast Asia Market Size and Forecast (2018-2029)
9.3.8 Australia Market Size and Forecast (2018-2029)
10 South America
10.1 South America Adalimumab Injection Sales Quantity by Type (2018-2029)
10.2 South America Adalimumab Injection Sales Quantity by Application (2018-2029)
10.3 South America Adalimumab Injection Market Size by Country
10.3.1 South America Adalimumab Injection Sales Quantity by Country (2018-2029)
10.3.2 South America Adalimumab Injection Consumption Value by Country (2018-2029)
10.3.3 Brazil Market Size and Forecast (2018-2029)
10.3.4 Argentina Market Size and Forecast (2018-2029)
11 Middle East & Africa
11.1 Middle East & Africa Adalimumab Injection Sales Quantity by Type (2018-2029)
11.2 Middle East & Africa Adalimumab Injection Sales Quantity by Application (2018-2029)
11.3 Middle East & Africa Adalimumab Injection Market Size by Country
11.3.1 Middle East & Africa Adalimumab Injection Sales Quantity by Country (2018-2029)
11.3.2 Middle East & Africa Adalimumab Injection Consumption Value by Country (2018-2029)
11.3.3 Turkey Market Size and Forecast (2018-2029)
11.3.4 Egypt Market Size and Forecast (2018-2029)
11.3.5 Saudi Arabia Market Size and Forecast (2018-2029)
11.3.6 South Africa Market Size and Forecast (2018-2029)
12 Market Dynamics
12.1 Adalimumab Injection Market Drivers
12.2 Adalimumab Injection Market Restraints
12.3 Adalimumab Injection Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
12.5 Influence of COVID-19 and Russia-Ukraine War
12.5.1 Influence of COVID-19
12.5.2 Influence of Russia-Ukraine War
13 Raw Material and Industry Chain
13.1 Raw Material of Adalimumab Injection and Key Manufacturers
13.2 Manufacturing Costs Percentage of Adalimumab Injection
13.3 Adalimumab Injection Production Process
13.4 Adalimumab Injection Industrial Chain
14 Shipments by Distribution Channel
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Adalimumab Injection Typical Distributors
14.3 Adalimumab Injection Typical Customers
15 Research Findings and Conclusion
16 Appendix
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
Table 1. Global Adalimumab Injection Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Table 2. Global Adalimumab Injection Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Table 3. AbbVie Basic Information, Manufacturing Base and Competitors
Table 4. AbbVie Major Business
Table 5. AbbVie Adalimumab Injection Product and Services
Table 6. AbbVie Adalimumab Injection Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 7. AbbVie Recent Developments/Updates
Table 8. Amgen Basic Information, Manufacturing Base and Competitors
Table 9. Amgen Major Business
Table 10. Amgen Adalimumab Injection Product and Services
Table 11. Amgen Adalimumab Injection Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 12. Amgen Recent Developments/Updates
Table 13. Sandoz Basic Information, Manufacturing Base and Competitors
Table 14. Sandoz Major Business
Table 15. Sandoz Adalimumab Injection Product and Services
Table 16. Sandoz Adalimumab Injection Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 17. Sandoz Recent Developments/Updates
Table 18. Fresenius Kabi Basic Information, Manufacturing Base and Competitors
Table 19. Fresenius Kabi Major Business
Table 20. Fresenius Kabi Adalimumab Injection Product and Services
Table 21. Fresenius Kabi Adalimumab Injection Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 22. Fresenius Kabi Recent Developments/Updates
Table 23. Biogen Basic Information, Manufacturing Base and Competitors
Table 24. Biogen Major Business
Table 25. Biogen Adalimumab Injection Product and Services
Table 26. Biogen Adalimumab Injection Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 27. Biogen Recent Developments/Updates
Table 28. Celltrion Basic Information, Manufacturing Base and Competitors
Table 29. Celltrion Major Business
Table 30. Celltrion Adalimumab Injection Product and Services
Table 31. Celltrion Adalimumab Injection Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 32. Celltrion Recent Developments/Updates
Table 33. Cadila Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 34. Cadila Pharmaceuticals Major Business
Table 35. Cadila Pharmaceuticals Adalimumab Injection Product and Services
Table 36. Cadila Pharmaceuticals Adalimumab Injection Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 37. Cadila Pharmaceuticals Recent Developments/Updates
Table 38. Bio-Thera Solutions, Ltd. Basic Information, Manufacturing Base and Competitors
Table 39. Bio-Thera Solutions, Ltd. Major Business
Table 40. Bio-Thera Solutions, Ltd. Adalimumab Injection Product and Services
Table 41. Bio-Thera Solutions, Ltd. Adalimumab Injection Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 42. Bio-Thera Solutions, Ltd. Recent Developments/Updates
Table 43. Hisun Biopharmaceutical Basic Information, Manufacturing Base and Competitors
Table 44. Hisun Biopharmaceutical Major Business
Table 45. Hisun Biopharmaceutical Adalimumab Injection Product and Services
Table 46. Hisun Biopharmaceutical Adalimumab Injection Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 47. Hisun Biopharmaceutical Recent Developments/Updates
Table 48. Innovent Biologics Basic Information, Manufacturing Base and Competitors
Table 49. Innovent Biologics Major Business
Table 50. Innovent Biologics Adalimumab Injection Product and Services
Table 51. Innovent Biologics Adalimumab Injection Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 52. Innovent Biologics Recent Developments/Updates
Table 53. Mylan Basic Information, Manufacturing Base and Competitors
Table 54. Mylan Major Business
Table 55. Mylan Adalimumab Injection Product and Services
Table 56. Mylan Adalimumab Injection Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 57. Mylan Recent Developments/Updates
Table 58. Zydus Group Basic Information, Manufacturing Base and Competitors
Table 59. Zydus Group Major Business
Table 60. Zydus Group Adalimumab Injection Product and Services
Table 61. Zydus Group Adalimumab Injection Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 62. Zydus Group Recent Developments/Updates
Table 63. Boehringer Ingelheim Basic Information, Manufacturing Base and Competitors
Table 64. Boehringer Ingelheim Major Business
Table 65. Boehringer Ingelheim Adalimumab Injection Product and Services
Table 66. Boehringer Ingelheim Adalimumab Injection Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 67. Boehringer Ingelheim Recent Developments/Updates
Table 68. Jiangsu Chia Tai-Tianqing Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 69. Jiangsu Chia Tai-Tianqing Pharmaceutical Major Business
Table 70. Jiangsu Chia Tai-Tianqing Pharmaceutical Adalimumab Injection Product and Services
Table 71. Jiangsu Chia Tai-Tianqing Pharmaceutical Adalimumab Injection Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 72. Jiangsu Chia Tai-Tianqing Pharmaceutical Recent Developments/Updates
Table 73. Shanghai Henlius Biotech Basic Information, Manufacturing Base and Competitors
Table 74. Shanghai Henlius Biotech Major Business
Table 75. Shanghai Henlius Biotech Adalimumab Injection Product and Services
Table 76. Shanghai Henlius Biotech Adalimumab Injection Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 77. Shanghai Henlius Biotech Recent Developments/Updates
Table 78. Global Adalimumab Injection Sales Quantity by Manufacturer (2018-2023) & (K Units)
Table 79. Global Adalimumab Injection Revenue by Manufacturer (2018-2023) & (USD Million)
Table 80. Global Adalimumab Injection Average Price by Manufacturer (2018-2023) & (US$/Unit)
Table 81. Market Position of Manufacturers in Adalimumab Injection, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2022
Table 82. Head Office and Adalimumab Injection Production Site of Key Manufacturer
Table 83. Adalimumab Injection Market: Company Product Type Footprint
Table 84. Adalimumab Injection Market: Company Product Application Footprint
Table 85. Adalimumab Injection New Market Entrants and Barriers to Market Entry
Table 86. Adalimumab Injection Mergers, Acquisition, Agreements, and Collaborations
Table 87. Global Adalimumab Injection Sales Quantity by Region (2018-2023) & (K Units)
Table 88. Global Adalimumab Injection Sales Quantity by Region (2024-2029) & (K Units)
Table 89. Global Adalimumab Injection Consumption Value by Region (2018-2023) & (USD Million)
Table 90. Global Adalimumab Injection Consumption Value by Region (2024-2029) & (USD Million)
Table 91. Global Adalimumab Injection Average Price by Region (2018-2023) & (US$/Unit)
Table 92. Global Adalimumab Injection Average Price by Region (2024-2029) & (US$/Unit)
Table 93. Global Adalimumab Injection Sales Quantity by Type (2018-2023) & (K Units)
Table 94. Global Adalimumab Injection Sales Quantity by Type (2024-2029) & (K Units)
Table 95. Global Adalimumab Injection Consumption Value by Type (2018-2023) & (USD Million)
Table 96. Global Adalimumab Injection Consumption Value by Type (2024-2029) & (USD Million)
Table 97. Global Adalimumab Injection Average Price by Type (2018-2023) & (US$/Unit)
Table 98. Global Adalimumab Injection Average Price by Type (2024-2029) & (US$/Unit)
Table 99. Global Adalimumab Injection Sales Quantity by Application (2018-2023) & (K Units)
Table 100. Global Adalimumab Injection Sales Quantity by Application (2024-2029) & (K Units)
Table 101. Global Adalimumab Injection Consumption Value by Application (2018-2023) & (USD Million)
Table 102. Global Adalimumab Injection Consumption Value by Application (2024-2029) & (USD Million)
Table 103. Global Adalimumab Injection Average Price by Application (2018-2023) & (US$/Unit)
Table 104. Global Adalimumab Injection Average Price by Application (2024-2029) & (US$/Unit)
Table 105. North America Adalimumab Injection Sales Quantity by Type (2018-2023) & (K Units)
Table 106. North America Adalimumab Injection Sales Quantity by Type (2024-2029) & (K Units)
Table 107. North America Adalimumab Injection Sales Quantity by Application (2018-2023) & (K Units)
Table 108. North America Adalimumab Injection Sales Quantity by Application (2024-2029) & (K Units)
Table 109. North America Adalimumab Injection Sales Quantity by Country (2018-2023) & (K Units)
Table 110. North America Adalimumab Injection Sales Quantity by Country (2024-2029) & (K Units)
Table 111. North America Adalimumab Injection Consumption Value by Country (2018-2023) & (USD Million)
Table 112. North America Adalimumab Injection Consumption Value by Country (2024-2029) & (USD Million)
Table 113. Europe Adalimumab Injection Sales Quantity by Type (2018-2023) & (K Units)
Table 114. Europe Adalimumab Injection Sales Quantity by Type (2024-2029) & (K Units)
Table 115. Europe Adalimumab Injection Sales Quantity by Application (2018-2023) & (K Units)
Table 116. Europe Adalimumab Injection Sales Quantity by Application (2024-2029) & (K Units)
Table 117. Europe Adalimumab Injection Sales Quantity by Country (2018-2023) & (K Units)
Table 118. Europe Adalimumab Injection Sales Quantity by Country (2024-2029) & (K Units)
Table 119. Europe Adalimumab Injection Consumption Value by Country (2018-2023) & (USD Million)
Table 120. Europe Adalimumab Injection Consumption Value by Country (2024-2029) & (USD Million)
Table 121. Asia-Pacific Adalimumab Injection Sales Quantity by Type (2018-2023) & (K Units)
Table 122. Asia-Pacific Adalimumab Injection Sales Quantity by Type (2024-2029) & (K Units)
Table 123. Asia-Pacific Adalimumab Injection Sales Quantity by Application (2018-2023) & (K Units)
Table 124. Asia-Pacific Adalimumab Injection Sales Quantity by Application (2024-2029) & (K Units)
Table 125. Asia-Pacific Adalimumab Injection Sales Quantity by Region (2018-2023) & (K Units)
Table 126. Asia-Pacific Adalimumab Injection Sales Quantity by Region (2024-2029) & (K Units)
Table 127. Asia-Pacific Adalimumab Injection Consumption Value by Region (2018-2023) & (USD Million)
Table 128. Asia-Pacific Adalimumab Injection Consumption Value by Region (2024-2029) & (USD Million)
Table 129. South America Adalimumab Injection Sales Quantity by Type (2018-2023) & (K Units)
Table 130. South America Adalimumab Injection Sales Quantity by Type (2024-2029) & (K Units)
Table 131. South America Adalimumab Injection Sales Quantity by Application (2018-2023) & (K Units)
Table 132. South America Adalimumab Injection Sales Quantity by Application (2024-2029) & (K Units)
Table 133. South America Adalimumab Injection Sales Quantity by Country (2018-2023) & (K Units)
Table 134. South America Adalimumab Injection Sales Quantity by Country (2024-2029) & (K Units)
Table 135. South America Adalimumab Injection Consumption Value by Country (2018-2023) & (USD Million)
Table 136. South America Adalimumab Injection Consumption Value by Country (2024-2029) & (USD Million)
Table 137. Middle East & Africa Adalimumab Injection Sales Quantity by Type (2018-2023) & (K Units)
Table 138. Middle East & Africa Adalimumab Injection Sales Quantity by Type (2024-2029) & (K Units)
Table 139. Middle East & Africa Adalimumab Injection Sales Quantity by Application (2018-2023) & (K Units)
Table 140. Middle East & Africa Adalimumab Injection Sales Quantity by Application (2024-2029) & (K Units)
Table 141. Middle East & Africa Adalimumab Injection Sales Quantity by Region (2018-2023) & (K Units)
Table 142. Middle East & Africa Adalimumab Injection Sales Quantity by Region (2024-2029) & (K Units)
Table 143. Middle East & Africa Adalimumab Injection Consumption Value by Region (2018-2023) & (USD Million)
Table 144. Middle East & Africa Adalimumab Injection Consumption Value by Region (2024-2029) & (USD Million)
Table 145. Adalimumab Injection Raw Material
Table 146. Key Manufacturers of Adalimumab Injection Raw Materials
Table 147. Adalimumab Injection Typical Distributors
Table 148. Adalimumab Injection Typical Customers
List of Figures
Figure 1. Adalimumab Injection Picture
Figure 2. Global Adalimumab Injection Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 3. Global Adalimumab Injection Consumption Value Market Share by Type in 2022
Figure 4. 40mg/0.8ml Examples
Figure 5. 20mg/0.4ml Examples
Figure 6. Global Adalimumab Injection Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 7. Global Adalimumab Injection Consumption Value Market Share by Application in 2022
Figure 8. Hospitals Examples
Figure 9. Clinics Examples
Figure 10. Others Examples
Figure 11. Global Adalimumab Injection Consumption Value, (USD Million): 2018 & 2022 & 2029
Figure 12. Global Adalimumab Injection Consumption Value and Forecast (2018-2029) & (USD Million)
Figure 13. Global Adalimumab Injection Sales Quantity (2018-2029) & (K Units)
Figure 14. Global Adalimumab Injection Average Price (2018-2029) & (US$/Unit)
Figure 15. Global Adalimumab Injection Sales Quantity Market Share by Manufacturer in 2022
Figure 16. Global Adalimumab Injection Consumption Value Market Share by Manufacturer in 2022
Figure 17. Producer Shipments of Adalimumab Injection by Manufacturer Sales Quantity ($MM) and Market Share (%): 2021
Figure 18. Top 3 Adalimumab Injection Manufacturer (Consumption Value) Market Share in 2022
Figure 19. Top 6 Adalimumab Injection Manufacturer (Consumption Value) Market Share in 2022
Figure 20. Global Adalimumab Injection Sales Quantity Market Share by Region (2018-2029)
Figure 21. Global Adalimumab Injection Consumption Value Market Share by Region (2018-2029)
Figure 22. North America Adalimumab Injection Consumption Value (2018-2029) & (USD Million)
Figure 23. Europe Adalimumab Injection Consumption Value (2018-2029) & (USD Million)
Figure 24. Asia-Pacific Adalimumab Injection Consumption Value (2018-2029) & (USD Million)
Figure 25. South America Adalimumab Injection Consumption Value (2018-2029) & (USD Million)
Figure 26. Middle East & Africa Adalimumab Injection Consumption Value (2018-2029) & (USD Million)
Figure 27. Global Adalimumab Injection Sales Quantity Market Share by Type (2018-2029)
Figure 28. Global Adalimumab Injection Consumption Value Market Share by Type (2018-2029)
Figure 29. Global Adalimumab Injection Average Price by Type (2018-2029) & (US$/Unit)
Figure 30. Global Adalimumab Injection Sales Quantity Market Share by Application (2018-2029)
Figure 31. Global Adalimumab Injection Consumption Value Market Share by Application (2018-2029)
Figure 32. Global Adalimumab Injection Average Price by Application (2018-2029) & (US$/Unit)
Figure 33. North America Adalimumab Injection Sales Quantity Market Share by Type (2018-2029)
Figure 34. North America Adalimumab Injection Sales Quantity Market Share by Application (2018-2029)
Figure 35. North America Adalimumab Injection Sales Quantity Market Share by Country (2018-2029)
Figure 36. North America Adalimumab Injection Consumption Value Market Share by Country (2018-2029)
Figure 37. United States Adalimumab Injection Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 38. Canada Adalimumab Injection Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 39. Mexico Adalimumab Injection Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 40. Europe Adalimumab Injection Sales Quantity Market Share by Type (2018-2029)
Figure 41. Europe Adalimumab Injection Sales Quantity Market Share by Application (2018-2029)
Figure 42. Europe Adalimumab Injection Sales Quantity Market Share by Country (2018-2029)
Figure 43. Europe Adalimumab Injection Consumption Value Market Share by Country (2018-2029)
Figure 44. Germany Adalimumab Injection Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 45. France Adalimumab Injection Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 46. United Kingdom Adalimumab Injection Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 47. Russia Adalimumab Injection Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 48. Italy Adalimumab Injection Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 49. Asia-Pacific Adalimumab Injection Sales Quantity Market Share by Type (2018-2029)
Figure 50. Asia-Pacific Adalimumab Injection Sales Quantity Market Share by Application (2018-2029)
Figure 51. Asia-Pacific Adalimumab Injection Sales Quantity Market Share by Region (2018-2029)
Figure 52. Asia-Pacific Adalimumab Injection Consumption Value Market Share by Region (2018-2029)
Figure 53. China Adalimumab Injection Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 54. Japan Adalimumab Injection Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 55. Korea Adalimumab Injection Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 56. India Adalimumab Injection Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 57. Southeast Asia Adalimumab Injection Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 58. Australia Adalimumab Injection Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 59. South America Adalimumab Injection Sales Quantity Market Share by Type (2018-2029)
Figure 60. South America Adalimumab Injection Sales Quantity Market Share by Application (2018-2029)
Figure 61. South America Adalimumab Injection Sales Quantity Market Share by Country (2018-2029)
Figure 62. South America Adalimumab Injection Consumption Value Market Share by Country (2018-2029)
Figure 63. Brazil Adalimumab Injection Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 64. Argentina Adalimumab Injection Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 65. Middle East & Africa Adalimumab Injection Sales Quantity Market Share by Type (2018-2029)
Figure 66. Middle East & Africa Adalimumab Injection Sales Quantity Market Share by Application (2018-2029)
Figure 67. Middle East & Africa Adalimumab Injection Sales Quantity Market Share by Region (2018-2029)
Figure 68. Middle East & Africa Adalimumab Injection Consumption Value Market Share by Region (2018-2029)
Figure 69. Turkey Adalimumab Injection Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 70. Egypt Adalimumab Injection Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 71. Saudi Arabia Adalimumab Injection Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 72. South Africa Adalimumab Injection Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 73. Adalimumab Injection Market Drivers
Figure 74. Adalimumab Injection Market Restraints
Figure 75. Adalimumab Injection Market Trends
Figure 76. Porters Five Forces Analysis
Figure 77. Manufacturing Cost Structure Analysis of Adalimumab Injection in 2022
Figure 78. Manufacturing Process Analysis of Adalimumab Injection
Figure 79. Adalimumab Injection Industrial Chain
Figure 80. Sales Quantity Channel: Direct to End-User vs Distributors
Figure 81. Direct Channel Pros & Cons
Figure 82. Indirect Channel Pros & Cons
Figure 83. Methodology
Figure 84. Research Process and Data Source